MarketDesk Focused U.S. Momentum ETF

FMTM

시가총액 US$2.73억

MarketDesk Focused U.S. Momentum ETF (FMTM) rapidly changed gears this September, now favoring small/mid-cap companies in the Health Care sector. FMTM's TTM P/E ratio dropped from 33.99x to 25.98x in two months, reflecting significant turnover. Its overlap with SPMO is now just 1%. My momentum analysis indicate these changes were primarily driven by three-month returns, which I consider too noisy to be relevant.

The MarketDesk Focused U.S. Momentum ETF invests in stable companies with upward price momentum. It rebalances monthly to ensure it always has stocks with growth momentum.

MarketDesk Focused U.S. Momentum ETF has delivered a 62.89% return since inception, outperforming nearly every other large-cap momentum ETF on the market. FMTM's quantitative, high-active-share strategy captures strong earnings growth trends, yet quality screens are only adequate, not robust. Portfolio concentration in technology and industrials, elevated volatility, and a 33.99x TTM P/E raise drawdown and valuation risk.

The New York Knicks' first NBA championship in 53 years has put Madison Square Garden Sports Corp. (NYSE:MSGS) back in the spotlight, but one momentum-focused ETF says the market had begun recognizing the opportunity long before the franchise captured the title.

MarketDesk Focused US Momentum ETF blends quality and momentum factors via a quantitative, monthly-rebalanced, equal-weighted approach targeting US stocks. FMTM's strategy dampens volatility versus classic momentum ETFs, achieving a standard deviation of 18 versus SPMO's 24, while maintaining competitive returns. The fund's high turnover (398% annualized) and dynamic sector allocation enhance diversification and reduce portfolio overlap with traditional momentum or S&P 500 ETFs.

MarketDesk Focused US Momentum ETF is an actively managed vehicle leveraging quantitative methodology to identify stocks exhibiting strong momentum characteristics while filtering out inefficient, overleveraged companies. FMTM has outperformed IVV, QQQ, and a few momentum ETFs since its inception in March 2025. However, with twelve full calendar months in the books, FMTM underperformed IVV in six, including in March, which reveals the strategy's limitations.